Accessibility Menu
 
Sol-Gel Technologies logo

Sol-Gel Technologies

(NASDAQ) SLGL

Current Price$79.46
Market Cap$259.75M
Since IPO (2018)-42%
5 Year-35%
1 Year+1,542%
1 Month-19%

Sol-Gel Technologies Financials at a Glance

Market Cap

$259.75M

Revenue (TTM)

$19.39M

Net Income (TTM)

$6.13M

EPS (TTM)

$-2.20

P/E Ratio

-36.13

Dividend

$0.00

Beta (Volatility)

0.46 (Low)

Price

$79.46

Volume

80,099.939

Open

$82.90

Previous Close

$79.46

Daily Range

$77.46 - $84.60

52-Week Range

$4.02 - $97.97

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sol-Gel Technologies

Industry

Pharmaceuticals

Employees

28

CEO

Moshe Arkin

Headquarters

Ness Ziona, 7403650, IL

SLGL Financials

Key Financial Metrics (TTM)

Gross Margin

99%

Operating Margin

-39%

Net Income Margin

-32%

Return on Equity

-24%

Return on Capital

-32%

Return on Assets

-20%

Earnings Yield

-2.77%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$259.75M

Shares Outstanding

3.27M

Volume

80.10K

Short Interest

0.00%

Avg. Volume

30.91K

Financials (TTM)

Gross Profit

$19.28M

Operating Income

$7.59M

EBITDA

$7.48M

Operating Cash Flow

$322.00K

Capital Expenditure

$47.00K

Free Cash Flow

$275.00K

Cash & ST Invst.

$24.00M

Total Debt

$991.00K

Sol-Gel Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$696.00K

+150.4%

Gross Profit

$587.00K

+111.2%

Gross Margin

84.34%

N/A

Market Cap

$259.75M

N/A

Market Cap/Employee

$7.64M

N/A

Employees

34

N/A

Net Income

$2.99M

+48.9%

EBITDA

$3.46M

+43.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$23.01M

+1.7%

Accounts Receivable

$1.97M

-45.3%

Inventory

$0.00

N/A

Long Term Debt

$496.00K

-43.5%

Short Term Debt

$495.00K

+15.1%

Return on Assets

-20.48%

N/A

Return on Invested Capital

-31.97%

N/A

Free Cash Flow

$0.00

N/A

Operating Cash Flow

$0.00

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MGNXMacroGenics, Inc.
$3.07+5.86%
OVIDOvid Therapeutics Inc.
$2.20+1.85%
ZNTLZentalis Pharmaceuticals, Inc.
$2.63+2.33%
ORMPOramed Pharmaceuticals Inc.
$3.42+0.88%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.31-0.02%

Questions About SLGL

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.